Successful Intravenous Thrombolysis of Central Retinal Artery Occlusion in a Patient with Giant Cell Arteritis
Main Article Content
Abstract
Importance: Central retinal artery occlusion (CRAO) is an ophthalmologic emergency, most often from non-arteritic etiology, but occasionally due to arteritic causes, especially giant cell arteritis (GCA), an inflammatory vasculitis affecting large and medium sized arteries. While thrombolytic therapy with intravenous tissue plasminogen activator (IV tPA) has gathered interest in non-arteritic CRAO, its role in arteritic CRAO remains unexplored. We report a case of successful visual recovery following intravenous thrombolysis in a patient with GCA-associated CRAO, and compare this outcome with current literature.
Observations: A patient presenting with acute monocular vision loss in her left eye was diagnosed with CRAO in the setting of active GCA and received IV tPA within 2.5 hours of symptom onset. Visual acuity, fundus findings, and safety outcomes were documented post-treatment. Following treatment, the patient demonstrated significant visual improvement, regaining functional acuity. This contrasts sharply with the typically poor visual prognosis in arteritic CRAO, despite corticosteroid therapy alone. In non-arteritic CRAO, IV tPA, when administered within 4.5 hours, has been shown to improve vision in 30–60% of cases, with an excellent safety profile and very low incidence of symptomatic intracranial hemorrhage. No previous studies however have reported successful thrombolysis in arteritic CRAO.
Conclusion: This case presents new evidence that early intravenous thrombolysis, in conjunction with corticosteroid therapy, may preserve vision in GCA-related CRAO by targeting a superimposed thrombotic component. While current guidelines do not support thrombolysis for arteritic CRAO, our findings suggest that a dual anti-inflammatory and thrombolytic approach could be effective in select patients. Further research is warranted to characterize patient selection criteria, optimize timing, and assess safety in this unique population.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Tripathy K, Shah SS, Waymack JR (2024). Central Retinal Artery Occlusion. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–
3. Hayreh SS, Zimmerman MB. Central retinal artery occlusion: visual outcome. Am J Ophthalmol. 2005 ;140(3): 376-391.doi:10.1016/j.ajo.2005.03.038
4. Olsen TW, Pulido JS, Folk JC, et al. (2017). Retinal and ophthalmic artery occlusions. Preferred Practice Pattern®. Ophthalmology. 2017;124(2): 120–143.doi:10.1016/jophtha.2016.09.024.
5. Lin JC, Song S, Ng, SM et al. (2023). Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev.2023 Jan 30;1(1):CD 1989.doi. 10.102/1465185.CD01989.pub3.
6. Hazin R, Dixon JA, Bhatti MT. Thrombolytic therapy in central retinal artery occlusion: cutting edge therapy, standard of care therapy, or impractical therapy? Curr Opin Ophthalmol. 2009;20(3): 210–218. Doi: 10.1097/ICU.0b013e328329b5d5.
7. Nakagawara, J, Minematsu, K, Okada, Y, et al. (2010). Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS). Stroke 2020;41(9): 1984-1989.
8. Chen, C.S, Lee, A.W, Campbell, B, et al. (2011). Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial. Stroke. 42(8): 2229-2234. doi.org/10.1161/STROKEAHA.110.589606.
9. Dumitrascu, OM, Newman NJ, Biousse V. Thrombolysis for central retinal artery occlusion in 2020: time is vision! J Neuroophthalmol. 2020;40 (3): 333–345.. doi:1.1097/WNO.0000000000001027.
10. Liu Y, Cao S, Zhao Y, et al. Network meta-analysis of different thrombolytic strategies for the treatment of central retinal artery occlusion. Semin Ophthalmol. 2024;39(2): 129–138. doi: 10.1080/08 820538.2023.2249549.
11. Aldrich, E.M, Lee, A.W, Chen, C.S, et al. Local intraarterial fibrinolysis administered in aliquots for the treatment of central retinal artery occlusion: the Johns Hopkins Hospital experience. Stroke. 2008; 39(6):1746–1750. doi: 10.1161/STROKEAHA.107.505404.
12. Schumacher M, Schmidt D, Jurklies B, et al. Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology. 2010;117(7): 13 67–1375.e1.doi: 10.1016,jophtha.2010.03.061
13. Cugati, S, Varma, D.D, Chen, C.S, et al. Treatment options for central retinal artery occlusion. Curr Treat Options Neurol. 2013;15(1): 63–77. doi: 10. 1007/s119940-012-0202-9.
14. Biousse V, Calvetti O, Bruce BB, et al. Thrombolysis for central retinal artery occlusion. J Neuroophthalmol. 2007;27(3): 215–230. Doi:10.10 97/WNO.0b013e31814b1f66.
15. Donaldson L, Nicholson P, Margolin E. Visual recovery in 2 cases of central retinal artery occlusion treated with prompt intra-ophthalmic artery fibrinolysis. J Neuroophthalmol. 2023;43(3): 383–386. doi.10/1097/WNO.0000000000001785.
16. Hayreh SS, Biousse V. Treatment of acute visual loss in giant cell arteritis: should we prescribe high-dose intravenous steroids or just oral steroids? J Neuroophthalmol. 2012;32(3): 278–287.doi: 10.1097/WNO.0b013e3182688218.
17. Duff IF, Falls HF, Linman JW. Anticoagulant therapy in occlusive vascular disease of the retina. AMA Arch Ophthalmol. 1951;46(6): 601–617. doi: 10.1001/1rchophth.1951.01700020615001.
18. Lee MS, Smith SD, Galor A, et al. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum. 2006;54(10): 3306–3309. doi: 10.1002/art.22141.
19. Donaldson, L, Margolin, E. (2022). Vision loss in giant cell arteritis. Pract Neurol. 22(2): 138–140. doi: 10.1136/practneurol-2021-002972.
20. Dziadkowiak, E, Chojdak-Łukasiewicz, J, Paradowski, B, et al. Isolated arteritis misdiagnosed as bilateral orbital tumors in a patient with acute ischemic stroke. Radiol Case Rep. 2022;17(10): 3927–3932.doi: 10.1016/j.rader.2022.07.023.
21. Boulanger JM, Lindsay MP, Gubitz G, et al. Canadian Stroke Best Practice Recommendations for acute stroke management: prehospital, emergency department, and acute inpatient stroke care, 6th edition, update 2018. Int J Stroke. 2018; 13(9): 949–984. doi:10.1177/1747493018786616.